About CCSB
|
News
|
Contact Us
|
Site Map
中文版
CSR
Investor Relations
Events
Contract Research
Contract Manufacturing
API Products
Antifungal
Immunosuppressant
Oncology
Cardiovascular
Peptide Drug
Anti-virus
Immunomodulating Agents
Others
Search Results
Home
> Search Result
Certification
--Please Seclect--
US DMF
CEP / Other DMF
GMP
Inspection
Category
--Please Seclect--
Antifungal
Immunosuppressant
Oncology
Cardiovascular
Peptide Drug
Anti-virus
Immunomodulating Agents
Others
Status
--Please Seclect--
Commercial
Development
Investigation
Completed process development
Products with Status
Development
count:11
Brivaracetam
357336-20-0
In-house
Development
Edoxaban Tosylate Monohydrate
1229194-11-9
In-house
Development
Abaloparatide
247062-33-5
In-house
Development
Etelcalcetide HCl
1334237-71-6
In-house
Development
Lanreotide Acetate
127984-74-1
In-house
Development
Sacubitril Sodium Salt
149690-05-1
In-house
Development
Setmelanotide Acetate
1504602-49-6
In-house
Development
Eltrombopag Olamine
496775-62-3
In-house
Development
Imeglimin hydrochloride
775351-61-6
In-house
Development
Selumetinib Sulfate
943332-08-9
In-house
Development
Trilaciclib Dihydrochloride
1977495-97-8
In-house
Development